Anoikis -

Anoikis

How the Extracellular Matrix Regulates Life-or-Death Decisions

Steven M. Frisch (Herausgeber)

Buch | Hardcover
VIII, 202 Seiten
2021 | 1st ed. 2021
Springer International Publishing (Verlag)
978-3-030-73854-9 (ISBN)
139,09 inkl. MwSt

Anoikis is defined broadly as apoptosis that is inhibited by appropriate cell-matrix interactions.  Normal and tumor cells vary widely in their sensitivity to anoikis, but, in general, metastatic tumor cells are inevitably anoikis-resistant.  In particular, tumor cells that possess a cancer stem cell or mesenchymal phenotype, arising from the oncogenic Epithelial-Mesenchymal Transition (EMT), are transcriptionally re-programmed to resist anoikis.  While the anoikis response occurs through the mitochondrial pathway typically found in other apoptotic responses (e.g., DNA damage, death receptors, oxidative stress), the regulation of anoikis by cell-matrix signalling is unique and only partially characterized.  The uniqueness of anoikis is: a. regulation by integrins, non-integrin matrix receptors, and the signaling complexes associated with them; b. regulation by metabolic changes occurring in response to attachment/detachment;  c. regulation by oncogenes and tumor suppressor genes d. regulation by tumor microenvironment;  e. regulation by EMT.

Steven M. Frisch received his Ph.D. in Biochemistry from the University of California, Berkeley (where he worked with Dr. Zena Werb, at U.C.S.F). Following postdoctoral training at the M.I.T. Center for Cancer Research, Dr. Frisch served on the faculties of Washington University, St. Louis and the Sanford-Burnham-Prebys Institute, and is currently a Professor of Biochemistry at West Virginia University. Dr. Frisch has published extensively in the area of cancer cell biology and is internationally recognized for his important contributions to the field.

PrefaceIntroduction
Chapter 1 The intersection of anoikis resistance and fatty acid metabolism in cancerChapter 2 Anoikis resistance in melanomaChapter 3 Anoikis mediated by stress-activated MAPK signaling pathwaysChapter 4 Metabolic Regulation of AnoikisChapter 5 Metabolic Reprogramming contributes to Anoikis resistance in Cancer CellsChapter 6 Role of the nuclear receptors in anoikisChapter 7 The roles of anoikis in cervical cancerChapter 8 Shc and the control of small GTPase dynamics in cellular anchorageChapter 9 Anoikis and the Human Gut Epithelium in Health and DiseaseChapter 10 Epithelial cell extrusion:  the prelude to anoikisChapter 11 Microtubule modifications and mitochondria:  role in anoikis

Erscheinungsdatum
Zusatzinfo VIII, 202 p. 6 illus.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 475 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Zellbiologie
Schlagworte Anoikis • Apoptosis • Cancer • cell-matrix signalling • epithelial-mesenchymal transition
ISBN-10 3-030-73854-X / 303073854X
ISBN-13 978-3-030-73854-9 / 9783030738549
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99